[Home]   [Full version]  

Fruit Flies, Death, and Immunity

Mar 28 ,General Science


University of Arkansas scientists have found an important mechanism that regulates the destruction of larval fruit fly salivary glands that could point the way to understanding programmed cell death in the human immune system.

Biology professor Michael Lehmann, graduate student Chike Cao and research assistant Yanling Liu recently published their findings in the Journal of Cell Biology.

Lehmann and his colleagues examined the expression of different proteins during the development and demise of larval salivary glands in Drosophila melanogaster, a common fruit fly. Previous studies have shown that steroids and other hormones trigger programmed cell death during normal development, such as the destruction of the tadpole tail during frog metamorphosis. However, little was known about what tells these hormones to act on a specific tissue at a given time.

"We wanted to know why one cell dies during steroid hormone release, while another one doesn't," Lehmann said.

Cell death, it turns out, is essential to life - without it, normal development can't take place, and this sometimes results in premature death. Lehmann points out that cancer cells have a defect in their cell death program, which is why they grow unchecked. Thus, understanding the mechanisms that control cell death can give scientists insights into how such deaths preserve life.

While investigating the Drosophila model, the researchers found that the life and death of the salivary gland cells depend upon a member of the Fork head protein family. This protein first protects the salivary glands from steroid-triggered death by acting as a "traffic cop," preventing the activation of two key genes responsible for cell death. However, the protein then disappears after a particular steroid pulse in a sequence of pulses. A subsequent steroid pulse triggers the death of the salivary gland cells.

To determine the extent of involvement of this protein, the researchers removed this protein at an earlier stage in development, which led to the activation of the cell-killing genes by an earlier steroid pulse and to premature cell death. Further, when the scientists caused the continued presence of the Fork head protein, the cell death genes remained inactive and the cells continued to live past their normal life span.

These findings have implications beyond fruit flies, as the molecular machinery that controls cell death is largely similar for invertebrates and vertebrates. The Fork head protein in Drosophila has homologs in humans, called FOXAs. These FOXAs are known to work together with corticosteroids, which control cell death in the immune system and are in therapeutic use to suppress allergic and inflammatory responses.

"Our research suggests that the FOXAs might have a similar role in cell death control in the immune system," Lehmann said. "This gives medical researchers a direction in which they might want to look."

Source: University of Arkansas

Related stories:

Medicine award kicks off Nobel Prize announcements
(AP) -- Two scientists who have won acclaim for research into the growth of cancer cells could be candidates for the Nobel Prize in medicine when the 2008 winners are presented on Monday, kicking off six days of Nobel announcements.
Researchers reveal Epstein-Barr virus protein contributes to cancer
Researchers at the University of Toronto have shown that the EBNA1 protein of Epstein-Barr virus (EBV) disrupts structures in the nucleus of nasopharyngeal carcinoma (NPC) cells, thereby interfering with cellular processes that normally prevent cancer development. The study, published October 3rd in the open-access journal PLoS Pathogens, describes a novel mechanism by which viral proteins contribute to carcinogenesis.
Breast cancer cells recycle to escape death by hormonal therapy
Many breast cancer cells facing potentially lethal antiestrogen therapy recycle to survive, researchers say.
Advance offers revolution in food safety testing
Microbiologists at Oregon State University have developed a new technology to detect illness-causing bacteria – an advance that could revolutionize the food industry, improving the actual protection to consumers while avoiding the costly waste and massive recalls of products that are suspected of bacterial contamination but are perfectly safe.
Scientists identify novel inhibitor of human microRNA
Scientists at The Wistar Institute and their colleagues have identified, for the first time, a molecule that can regulate microRNAs – short strands of RNA that play a vital role in gene expression and are closely associated with cancer. The discovery points the way to the development of a new generation of cancer drugs.
Researchers identify novel mechanism to reduce nervous system inflammation
Researchers at Georgetown University Medical Center have discovered a new way to limit inflammation caused by the activation of microglia - key immune cells in the brain. Although the role of such cells is to "clean up damage" after injury, they often worsen the damage by releasing toxic inflammatory factors.
Scientists deliver toxic genes to effectively kill pancreatic cancer cells
A research team, led by investigators at the Department of Surgery at Jefferson Medical College of Thomas Jefferson University and the Kimmel Cancer Center at Jefferson, has achieved a substantial "kill" of pancreatic cancer cells by using nanoparticles to successfully deliver a deadly diphtheria toxin gene. The findings – set to be published in the October issue of Cancer Biology & Therapy – reflect the first time this unique strategy has been tested in pancreatic cancer cells, and the success seen offers promise for future pre-clinical animal studies, and possibly, a new clinical approach.
Scientists develop new, more sensitive nanotechnology test for chemical DNA modifications
Researchers at The Johns Hopkins University School of Medicine in Baltimore have developed a novel test to screen for chemical modifications to DNA known as methylation. The technology potentially could be used both for early cancer diagnoses and for assessing patients' response to cancer therapies.

News discussion:

General Science news

[Home]   [Full version]